about
Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue TargetingMajor Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral SclerosisDialysis-related amyloidosis: challenges and solutionsRediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.Decoding the Structural Bases of D76N ß2-Microglobulin High Amyloidogenicity through Crystallography and Asn-Scan Mutagenesis.A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis.Folic Acid Inhibits Amyloid β-Peptide Production through Modulating DNA Methyltransferase Activity in N2a-APP Cells.Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS.In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study.Molecular pathogenesis of human amyloidosis: Lessons from β2 -microglobulin-related amyloidosis.Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance.Capillary electrophoresis analysis of different variants of the amyloidogenic protein β2 -microglobulin as a simple tool for misfolding and stability studies.Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.Salt-induced formations of partially folded intermediates and amyloid fibrils suggests a common underlying mechanism.Biophysical Aspects of Alzheimer's Disease: Implications for Pharmaceutical Sciences : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms
P2860
Q26744469-C7C83A31-1F2C-4AE8-BCE0-761637F9A033Q26744608-DCA85E6A-5328-4AD8-A172-F26742B61347Q28075306-C0A1CE27-A6B1-460A-BD48-8DA73D6AE506Q33799767-AD8FE8B7-C7DE-4702-ADBB-1E95A1AE60C8Q35857382-1980B054-5A61-4515-8C10-634BCC7D634FQ36159473-C8216212-01E4-4372-9B4D-74FD0266F93BQ36247488-D1C76347-BBAD-4FF7-8DC2-53BC6A6049AFQ36850057-7CB2D33E-6C9A-46D0-A9C4-019706FB8158Q37061542-E63E3372-8218-4B54-848B-21BE2395EE56Q38771098-0A3C9CE0-C161-4319-BF37-26DD65C6B88FQ39126169-5AB436CB-46A0-4EE7-B0A1-2A32221199D0Q40826378-6B029F0B-E4EB-4B05-9E70-9B96805C3F88Q41106725-1F8D23E8-3F33-4801-A8FB-AF047FB50738Q47277790-A7B8B8D1-75AB-4274-924C-82736B172467Q47722422-0120188B-BB15-4E9E-A9F3-6353B4C04FCDQ57159243-A0684E7A-B1A5-4AA9-9586-50BBDDCFE632
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Systemic amyloidosis: lessons from β2-microglobulin.
@ast
Systemic amyloidosis: lessons from β2-microglobulin.
@en
type
label
Systemic amyloidosis: lessons from β2-microglobulin.
@ast
Systemic amyloidosis: lessons from β2-microglobulin.
@en
prefLabel
Systemic amyloidosis: lessons from β2-microglobulin.
@ast
Systemic amyloidosis: lessons from β2-microglobulin.
@en
P2860
P921
P356
P1476
Systemic amyloidosis: lessons from β2-microglobulin
@en
P2093
Monica Stoppini
P2860
P304
P356
10.1074/JBC.R115.639799
P407
P50
P5008
P577
2015-03-06T00:00:00Z